ClinicalTrials.gov
public full text
Public Domain
Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)
The purpose of this study is to determine which of 3 different doses of tenecteplase (TNK) is better for treating stroke patients and if TNK offers an advantage over currently available treatment with tissue plasminogen activator (tPA).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tenecteplase Treatment in Ischemic Stroke Registry#1113276
- Safety Evaluation of 3K3A-APC in Ischemic Stroke#1100809
- Prospective Analysis of the Use of TEG in Stroke Patients#1031498
- Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)#870974
- A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes#814030
Record · ID 1032558
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive